Article & News

Mumbai: Kiran Mazumdar-Shaw, executive chairperson of biotech giant Biocon and the voice of the Indian biotechnology industry, has proposed sweeping reforms in the country’s drug

The European Commission has granted marketing authorization for Dr. Reddy’s Laboratories’ AVT03 (denosumab), a biosimilar referencing Prolia and Xgeva, for use across the European Union

Food is fuel for the body. In most people, islet cells in the pancreas secrete insulin that converts food into usable energy. But in those

Generic drugmaker Granules India subsidiary Granules Life Sciences (GLS), located in Hyderabad, has received U.S. Food and Drug Administration (U.S. FDA) approval for a product

Kiran Mazumdar-Shaw, founder and chairperson of Biocon Group, has been recognized as the Second Most Generous Woman Philanthropist in the EdelGive Hurun India Philanthropy List

Mounjaro, the breakthrough obesity and diabetes drug from Eli Lilly and Company, has become India’s highest-selling pharmaceutical brand in October, according to fresh data from

‘Talking’ to cells without influencing genes or molecules: it can be done by influencing bioelectric fields. By manipulating the bioelectric fields in organisms like planaria

The Indian pharmaceutical industry’s defining trend currently is the shift from volume-led growth to value- and innovation-led expansion. Indian companies are investing significantly in R&D,

There is a need to redefine Glucagon-Like Peptide-1 (GLP-1) therapy to adopt metabolism first path towards diabetes care, says Hummsa Biotech founder Harshad Lalwani.“Biotechnology company,

A research team has developed pioneering technology that enables human kidney organoids to be produced on a scalable basis. These organoids can then be combined